CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity
Canadian Association of Radiologists Journal · 2025-08 · 76 (3) · 400-416
DOI: 10.1177/08465371241311253 ↗Kurz gefasst
Leitlinie in der Zeitschrift Canadian Association of Radiologists Journal, online erschienen am 11.01.2025. Verfasst von Adam Byrne und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Disease, Immunology & Allergy, University of Ottawa, Ottawa, ON, Canada. Hauptthemen laut MEDLINE: Contrast Media, Drug Hypersensitivity. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Contrast media, including iodinated contrast media and gadolinium-based contrast agents, are commonly administered pharmaceuticals with excellent safety profiles. However, a minority of the population may experience a hypersensitivity reaction following intravenous administration. Hypersensitivity reactions can be immediate or delayed, and range from mild, such as urticaria, to severe, including anaphylaxis. There is emerging evidence that longstanding pretreatment protocols, such as diphenhydramine and corticosteroids, are ineffective and have the potential for side effects and other harms. Moreover, the evidence for efficacy on which this practice is based is weak and outdated. A joint collaborative working group of representatives from the Canadian Association of Radiologists and the Canadian Society of Allergy and Clinical Immunology was assembled to inform medical professionals and hospital policies regarding hypersensitivity reactions to contrast media. The objectives of the working group were to provide an overview of the epidemiology, physiology, risk factors, and types of hypersensitivity reactions; to synthesize the evidence for pretreatment strategies that minimize the risk of a breakthrough reaction for both iodinated contrast media and gadolinium-based contrast agents; to review the allergy investigations used to evaluate patients with a history of severe hypersensitivity reaction; and to provide an overview of existing guidelines. Following appraisal of the evidence, the working group established recommendations based on consensus in this practice guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Disease, Immunology & Allergy, University of Ottawa, Ottawa, ON, Canada.
- Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
- Department of Radiology, University of Ottawa, Ottawa, ON, Canada.
- Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- Department of Radiology, University of Manitoba, Winnipeg, MB, Canada.
- St. Boniface General Hospital, Winnipeg, MB, Canada.
ORCID-Profile: D Blair Macdonald, Iain D C Kirkpatrick, Courtney R Green, Ana Maria Copaescu, Matthew D F McInnes, Andreu F Costa
Zitieren
APA
Byrne, A., Macdonald, D. B., Kirkpatrick, I. D. C., Pham, M., Green, C. R., Copaescu, A. M., McInnes, M. D. F., Ling, L., Ellis, A., & Costa, A. F. (2025). CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity. Canadian Association of Radiologists Journal, 76(3), 400-416. https://doi.org/10.1177/08465371241311253
Vancouver
Byrne A, Macdonald DB, Kirkpatrick IDC, Pham M, Green CR, Copaescu AM, et al. CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity. Canadian Association of Radiologists Journal. 2025;76(3):400-416. doi:10.1177/08465371241311253
BibTeX
@article{Byrne2025,
author = {Byrne, Adam and Macdonald, D Blair and Kirkpatrick, Iain D C and Pham, Magali and Green, Courtney R and Copaescu, Ana Maria and McInnes, Matthew D F and Ling, Ling and Ellis, Anne and Costa, Andreu F},
title = {CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity},
journal = {Canadian Association of Radiologists Journal},
year = {2025},
volume = {76},
number = {3},
pages = {400--416},
doi = {10.1177/08465371241311253}
}
EUVIMED